RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All WHO updates
WHO
REGULATORY UPDATE
1st Invitation to Manufacturers of Therapeutics for Sickle Cell Disease to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit (PQT)
Published: 9/28/2026Detected: 8/13/2026

Summary preview

Launches the first WHO PQT invitation for manufacturers to submit an Expression of Interest (EOI) for evaluation of hydroxyurea products for the treatment of sickle cell disease, with emphasis on child-appropriate, safe…

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
rare_diseases
pediatrics
hematology
clinical
quality
#WHO prequalification
#PQT
#expression of interest (EOI)
#hydroxyurea
#sickle cell disease

Official Source Document
Source Verified

Access the original document directly from WHO.

View Official Document

More from WHO

  • Invitation to a Webinar on managing reportable changes11/16/2026
  • WHO Prequalifies Two STANDARD Q Malaria Rapid Diagnostic Tests11/16/2026
  • VCP Updates - October 202611/16/2026
  • In Vitro Diagnostics Assessment Sessions for 202711/16/2026
  • New WHO Emergency Use Listing for Ebola diagnostics11/16/2026

Get WHO alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.